Search

everythinglearnresearchcommunity

for

Search:↓

The platform effectively grows lung cancer cell spheroids for drug testing.

The combination of propylene glycol and Tween® 80 improves finasteride gel effectiveness.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Composite biodegradable biomaterials can improve diabetic wound healing but need more development for clinical use.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Nanocarriers can improve skin treatments by effectively delivering drugs and enhancing skin hydration.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

Hair transplant surgeons did not agree on which drugs to use except for local anesthetics, and there was no strong evidence supporting their drug choices.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Finasteride works best in 6 months and lasts 6 years.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.